Day 2 will cover how advances in areas such as genome-editing, RNA-based medicine, cellular therapies and regenerative medicine, and the advent of other new technology are impacting therapeutic developments. Examples from the field of oncology will serve as illustrations of the revolution in health arising from these. An important theme will be the ability to accelerate health improvements through partnership between academia and industry.

June 10 - Day 2	From precision health to new diagnostics and therapies
Time	Title	Speakers
Chair	TBD
08:30-09:00	Policy to promote international data sharing in a time of disruption	Yann Joly, U. McGill U., Canada
09:00-09:30	Biobanking and Precision Medicine in Malaysia: A Continuum of Ethical, Legal and Societal Issues	Amnah Azahar, Universiti Teknologi MARA, Malaysia
09:30-10:00	Advanced medical technologies and their ELSI impact- An India-specific analysis	Athira Nair, National University of Advanced Legal Studies, IN
Break
Chair	TBD
10:30-11:00	Cancer	Natini Jinawath, Mahidol University, Thailand
11:00-11:30	Brain health 1	Stéphanie Debette, U. Bordeaux, France
11:30-12:00	Brain health 2	Vorapun Senanarong, Mahidol University, Thailand
Lunch
Chair	TBD
13:00-13:30	Multiple sclerosis and autoimmune disorders	Stephen Sawcer, U. Cambridge, UK
13:30-14:00	Metabolic disease	Thipwimol Tim-aroon, Mahidol University, Thailand
14:00-14:30	Rare disease	Vorasuk Shotelersuk, Chulalongkorn University, Thailand
14:30-15:00	Childhood disease	Tomi Pastinen, Children's Mercy Hospital, US
Break
Chair	TBD
15:30-16:00	Roles of Runx3 in gut immune tolerance	Ichiro Taniuchi, RIKEN IMS, Japan
16:00-16:30	KIR typing and prediction of bone marrow transplantation	Fumi Matsuda, University of Kyoto, Japan
16:30-17:00	Potential RNA based medicine: SINEUPs that upregulate target mRNA translation in the disease models	Hazuki Takahashi, RIKEN IMS, Japan